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As the prevalence of asthma, particularly
among urban residents, has escalated over
the past three decades (Aligne et al. 2000;
Mannino et al. 1998, 2002), ambient air pol-
lutants, especially ozone and particulate mat-
ter (PM), have come under scrutiny as stimuli
of asthma exacerbations. O3 is a potent lung
irritant causing inﬂammatory changes in the
lung and decreases in lung function (Buchdahl
et al. 2000; McConnell et al. 2002; Mortimer
et al. 2000, 2002). PM with an aerodynamic
diameter of ≤ 10 µm (PM10) and ≤ 2.5 µm
(PM2.5) has been linked to increases in respi-
ratory symptoms, emergency department vis-
its for asthma, and decreases in lung function
(Delﬁno et al. 2002; McConnell et al. 2003;
Norris et al. 1999; van der Zee et al. 1999; Yu
et al. 2000).
Children with asthma are particularly
at risk for adverse health effects of air pollu-
tants including PM and O3 (Boezen et al.
1999; Delfino et al. 2002; McConnell et al.
1999; Norris et al. 1999; Ostro et al. 2001).
New lines of inquiry suggest that there may be
particularly sensitive subpopulations even
within this group. Because air pollutants are
thought to stimulate a generalized inﬂamma-
tory reaction in the asthmatic airway, several
investigators have examined whether use of
maintenance anti-inflammatory medication
protects against the adverse effects of air pollu-
tants, with mixed results: Some have reported
protective effects (Delﬁno et al. 2002; Mortimer
et al. 2000; Peters et al. 1997), whereas others
instead have found that only those children
using maintenance medications show associa-
tions between pollutant exposure and respira-
tory symptoms (Gent et al. 2003). Children
experiencing a respiratory infection—another
potent stimulus of airway inﬂammation—may
also have increased susceptibility to the effects of
air pollution (Chauhan et al. 2003; Delfino
et al. 2002).
Based on the evidence for adverse health
effects, U.S. National Ambient Air Quality
Standards (NAAQS) were recently revised to
lower the allowable ambient exposure to O3
using a daily 8-hr maximum reference and
to introduce a daily and annual standard for
PM2.5 [U.S. Environmental Protection
Agency (EPA) 1997]. Although there have
been improvements in some indicators of air
pollution, many urban areas have not attained
the new O3 and PM2.5 standards (U.S. EPA
2002). It is important to examine whether
current ambient levels of pollutants at or near
current standards are negatively affecting the
health of sensitive subpopulations.
Detroit, Michigan, offers an ideal setting
for elucidating urban environmental inﬂuences
on childhood asthma. Detroit reflects many
demographic trends seen in urban areas around
the country. A high proportion of city residents
have low income and are African American or
Latino. Asthma prevalence among children is
high in Detroit, with 14.3% reporting active
physician-diagnosed asthma and an additional
14.3% with undiagnosed asthma (Joseph et al.
1996). Asthma hospitalization rates for chil-
dren in Detroit are more than three times the
statewide average (Michigan Department of
Community Health 2002). In addition,
Detroit and surrounding Wayne County have
a long history of elevated air pollution and are
currently in nonattainment of the newer PM2.5
and O3 standards. Detroit is the site of the
busiest U.S.–Canadian border crossing for
truck trafﬁc (3,486,110 trucks/year). Typical
daily traffic volumes for major highways in
Detroit range from 47,000 to 153,000 vehicles
(Michigan Department of Transportation
2001). Nearby point sources for pollutants
include coal-fired utilities, municipal waste
incineration, sewage sludge incineration,
reﬁneries, iron/steel manufacturing, coke ovens,
and chemical plants (Keeler et al. 2002).
We hypothesized that ambient levels of
PM and O3 in Detroit communities would be
associated with ﬂuctuations in lung function
among asthmatic children. We expected that
more severe asthma, as indicated by concurrent
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In a longitudinal cohort study of primary-school–age children with asthma in Detroit, Michigan,
we examined relationships between lung function and ambient levels of particulate matter ≤ 10 µm
and ≤ 2.5 µm in diameter (PM10 and PM2.5) and ozone at varying lag intervals using generalized
estimating equations. Models considered effect modiﬁcation by maintenance corticosteroid (CS)
use and by the presence of an upper respiratory infection (URI) as recorded in a daily diary among
86 children who participated in six 2-week seasonal assessments from winter 2001 through spring
2002. Participants were predominantly African American from families with low income, and
> 75% were categorized as having persistent asthma. In both single-pollutant and two-pollutant
models, many regressions demonstrated associations between higher exposure to ambient pollu-
tants and poorer lung function (increased diurnal variability and decreased lowest daily values for
forced expiratory volume in 1 sec) among children using CSs but not among those not using CSs,
and among children reporting URI symptoms but not among those who did not report URIs. Our
findings suggest that levels of air pollutants in Detroit, which are above the current National
Ambient Air Quality Standards, adversely affect lung function of susceptible asthmatic children.
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would confer additional susceptibility to the
effects of air pollution. Additionally, we
expected that co-inﬂammatory changes associ-
ated with a contemporaneous respiratory infec-
tion would increase the adverse effects of
higher pollutant levels on measures of lung
function. We were most interested in effects
seen in the ﬁrst few days after exposure that we
felt were most likely to reﬂect inﬂammatory, as
opposed to acute bronchospastic, asthmatic
changes. Because the inflammatory changes
represented by children using inhaled CSs and
those with respiratory infection are likely to be
different, we did not necessarily expect that the
pollution effect lag structures would be the
same for both types of children.
Materials and Methods
Community Action Against Asthma
Partnership
There is a strong history of community-based
participatory research (CBPR) partnerships in
Detroit aimed at addressing asthma and other
health-related issues (Israel et al. 2003). The
study reported here is from Community
Action Against Asthma (CAAA), a project of
the CBPR partnership Michigan Center for
the Environment and Children’s Health. The
CAAA partnership involves a steering commit-
tee composed of representatives of community-
based organizations, health service agencies,
an academic institution, and a community
member at large that guided all phases of the
research (see Acknowledgements for list of part-
ners). The steering committee’s role included
the conceptualization of the research questions
and methods, particularly related to interac-
tions with the community, schools, and study
participants; the design of data collection
instruments and processes; the hiring of staff;
and the interpretation and dissemination of
research results (Edgren et al. 2005; Parker
et al. 2003). CAAA involved a longitudinal
epidemiologic cohort study of the effects of
PM and O3 on the respiratory health of chil-
dren with asthma (present results) and a ran-
domized controlled trial of an intervention
involving home visits by community outreach
workers to assist families in reducing exposure
to indoor asthma triggers (Parker et al. 2003).
These studies were conducted in two commu-
nities within Detroit (eastside and southwest)
that demographically have a high proportion of
low-income residents from African-American
and Latino ethnic groups.
Exposure Assessment
Ambient monitoring sites were established on
the rooftop of a representative school in both
southwest and eastside Detroit to assess com-
munity-level exposures to PM and O3. Two-
week seasonal measurement campaigns were
conducted for 11 seasons commencing in the
fall (October) of 1999 and ending in the
spring (May) of 2002.
Monitor placement. Many previous stud-
ies to assess health effects of air pollutants
have used exposure data from the nearest
available monitor (often existing state or fed-
erally mandated monitoring sites). These
often urban-scale monitoring sites, as deﬁned
by the U.S. EPA (1997), are designed to rep-
resent exposure to large populations, in a geo-
graphic area up to 100 km in diameter. Our
study sought to quantify community-level
exposure within two Detroit communities,
with the possibility that exposures between
the two communities may be different (Keeler
et al. 2002). Although the centroid of south-
west Detroit study participants was 15 km
from the centroid of eastside Detroit study
participants, we determined on examination
of the preexisting air monitoring sites in
Detroit that additional community-level sites
would need to be established for the sole
purpose of this study to obtain more accurate
measures of exposure. Each community mon-
itoring site was established near the centroid
of the study participants. Of the 86 children
included in the data analyses for this report
(see “Pulmonary function measures,” below),
82 were located within 5 km of their respec-
tive community monitoring location, resulting
in great improvement in exposure estimation
when compared with the preexisting monitor-
ing sites in Detroit or with the geographic
representativeness of exposure estimates for
many previous studies. The remaining four
children were in the eastside Detroit commu-
nity, 6–7.5 km from the community moni-
toring site.
U.S. EPA monitoring guidelines for PM
and O3 recommend sampler inlets be placed
between 3 and 15 m above ground level
because of surface reactivity and aerosol re-
suspension concerns near ground level (U.S.
EPA 1998). Because of the landscape of the
built environment in urban areas, it has been
suggested that rooftop locations (up to four
stories in height) serve as representative loca-
tions for pollutant exposure monitoring (Chow
et al. 2002). Using these guidelines, we selected
the community-level monitoring locations on
elementary school rooftops, with sampler
inlets 5–6 m above ground level as previously
described (Keeler et al. 2002).
Field measurements. We performed 24-hr
measurements of PM2.5 and PM10 at each com-
munity sampling location using Teﬂon-coated
aluminum cyclone inlets and ﬁlter-pack assem-
blies (University Research Glassware, Carrboro,
NC) with 2-µm–pore 47-mm Teflon (poly-
tetrafluoroethylene) membrane filters (Pall
Life Sciences, Ann Arbor, MI). Samples were
collected at a flow rate of 16.7 L/min from
0800 hr to 0800 hr, and the total volume of air
sampled was measured with calibrated dry test
meters (Schlumberger, Owenton, KY).
Ambient measurements of O3 and meteo-
rologic variables were also made at each com-
munity sampling location. O3 was monitored
continuously and logged as 30-min average
values (Dasibi Environmental, Glendale, CA).
Standard meteorologic variables including
temperature, atmospheric pressure, relative
humidity, wind speed, and wind direction
(R.M. Young Co., Traverse City, MI) were
also recorded in 30-min intervals at each of
the community measurement sites (Keeler
et al. 2002).
Laboratory analyses. All sample handling,
processing, and analysis took place in a class
100 clean laboratory (University of Michigan
Air Quality Laboratory, Ann Arbor, MI)
uniquely suited for ultratrace element analysis
with an emphasis on environmental deter-
minations. All gravimetric determinations
of Teflon filters for PM were made using
a microbalance (Mettler MT-5; Mettler
Toledo, Columbus, OH) in a temperature/
humidity-controlled environment. Standard
protocols included the use of field blanks,
filter-lot blanks, laboratory blanks, replicate
analyses, and externally certified standard
weights for all gravimetric analyses for quality
assurance and quality control purposes. The
detection limit for mass determination, cal-
culated as three times the standard deviation
of seven replicate ﬁlter measures, was 5.1 µg.
This corresponds to a detection limit of
0.2 µg/m3 for a 24-hr sample collected at
16.7 L/min.
For PM, daily PM2.5 and PM10 measure-
ments were the exposure variables used in the
health analysis. For O3, the daily mean O3
concentration and the rolling 8-hr averages
were calculated. With consideration for the
new U.S. EPA standard (U.S. EPA 1997), the
maximum 8-hr average in a 24-hr period was
called the O3 8-hr peak and analyzed as a sepa-
rate exposure variable.
Recruitment and Enrollment
An asthma screening questionnaire was mailed
and/or hand delivered to parents of 9,627
children, 7–11 years of age, who attended one
of 44 elementary schools in the eastside and
southwest areas of Detroit (Lewis et al. 2004).
Items on the questionnaire included parent
report of their child’s frequency of respiratory
symptoms, presence of physician diagnosis of
asthma, and frequency of doctor-prescribed
asthma medication use. Among the 3,067
returned questionnaires, 708 were eligible for
the study, based on the inclusion criteria that
responses on the screening questionnaire be
consistent with current persistent asthma and
that the address be within the geographic
boundaries of the study. We successfully con-
tacted 510 of those eligible and invited them
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enrolled. Thirty children were lost to follow-
up between obtaining informed consent
and commencing the study; therefore, the
298 children who began the study serve as the
study cohort. There were no signiﬁcant differ-
ences in demographic or asthma characteristics
between the 328 children that enrolled in the
study and the 179 who were contacted but
chose not to enroll, or between the 298 chil-
dren that began the study and the 30 who
were lost to follow-up before the study began
(Lewis et al. 2004). There were also no demo-
graphic differences between the 3,067 who
returned screening questionnaires and the
86 children for whom lung function data are
presented here.
Outcome Assessment
Pulmonary function measures. Each child was
asked to complete three consecutive expira-
tory maneuvers in the morning and again in
the evening on 14 consecutive days during
each of the 11 seasonal measurement periods
using a hand-held digital lung function moni-
toring device (AirWatch; iMetrikus Inc.,
Carlsbad, CA). The Airwatch devices are cali-
brated at the factory and are stated by the
manufacturer to retain calibration for life. We
did not attempt to independently calibrate
the devices.
Peak flow (PF) and forced expiratory
volume in 1 sec (FEV1) were measured.
Although it would have been desirable to
examine additional measures of airway
obstruction, such as mid-volume ﬂows [forced
expiratory ﬂow between 25 and 75% of vital
capacity (FEF25–75)], these were not available
from simple hand-held devices at the time of
the study. During the first five seasons, all
expiratory maneuvers were carried out at
home. Preliminary review of the data raised
concerns about quality of these expiratory
maneuvers. Therefore, for the ﬁnal six seasons
we switched to using the newly available
AirWatch 2 model, which included error
messages both for quality and length of expi-
ratory maneuver. In addition, all weekday
morning blows during the final six seasons
were performed at school under observation
and coaching by research staff. To maximize
the efficiency of limited staff, this required
restricting participation to those 86 children
who attended a school with at least two other
study participants. Other than being on aver-
age 6 months younger, these 86 children did
not differ signiﬁcantly in demographic char-
acteristics or in intervention group assign-
ment from those who did not continue with
pulmonary function measures in the last six
seasons. These protocol changes produced
substantial improvement in the quality of the
expiratory maneuvers. Results presented here
are based on these final six seasons of data
[winter 2001 (February 10–23), spring 2001
(May 5–18), summer 2001 (July 14–27), fall
2001 (September 22–October 5), winter
2002 (January 18–31), and spring 2002
(May 18–31)].
Lung function parameters of interest were
diurnal variability in these measures, as well as
the lowest value of the day. We deﬁned vari-
ability as the difference between morning and
evening value divided by the larger of the two
values for that day. Variability increases during
asthma exacerbation and was expected a priori
to be higher in response to high pollution
exposure. Lowest daily value, measured as per-
cent predicted for sex, age, height, and ethnic-
ity (Hankinson et al. 1999), was deﬁned as the
lower of the morning and evening values
for that day. High pollution exposure was
hypothesized to be associated with reduction
in lowest daily value. Data were analyzed for
days when a valid measurement was obtained
in both morning and evening. A valid measure
was deﬁned as one obtained on an error-free
expiratory maneuver. We excluded extreme
measures, which we felt were more likely to be
attributable to undetected errors in technique
than to be truly representative of the child’s
respiratory health. For FEV1, we defined
extreme as being > 140% or < 30% predicted.
Medication and symptom diary. As part
of the 2-week seasonal measurements, the
child’s primary caregiver completed a medica-
tion and symptom diary at the end of each day.
Children were considered to have an upper res-
piratory tract infection (URI) on any day for
which the caregiver checked “yes” for “Does
your child have a cold, the ﬂu, or other respira-
tory infection today?” Caregivers also wrote in
the number of times each of the asthma med-
ications were administered that day. Children
were deﬁned as being on a CS if, and only if,
a) at least 7 of the 14 diary days were com-
pleted and b) the parent reported use of an
inhaled or oral steroid for ≥ 50% of the days
for which the diary was completed. The assess-
ment of whether or not a child was on a CS
was made for each season independently.
Each participating caregiver was inter-
viewed face to face annually to obtain informa-
tion about family demographics, the child’s
health status, and the perceived exposure of the
child to tobacco smoke.
Analysis Methods
We examined descriptive statistics and bivariate
analyses of exposures with health outcomes
and then examined multivariable regression
models that included interaction terms between
exposure measures and CS use or, alternatively,
presence of a URI. We used generalized
estimating equations (GEE) (exchangeable
covariance structure), a multivariate analog of
linear regression to account for the within-
participant correlation of the repeated measures.
GEE was chosen over generalized linear mod-
els because of the non-normally distributed
exposure data.
With respect to timing of exposures, we
examined outcomes occurring 1 and 2 days
after the day that exposure was assessed (lag 1
and lag 2). In addition we considered out-
comes associated with the average daily expo-
sure 3–5 days before the outcome (lag 3–5).
Covariates in the ﬁnal models included sex,
home location, annual family income, presence
of one or more smokers in household, race,
season (entered as dummy variables), and para-
meters to account for intervention group
effect. Home location (eastside vs. southwest)
was determined by ZIP code of residence.
Caregivers were asked to identify their child’s
race, and responses were categorized as African
American or not African American. Annual
family income was asked as a multiple choice
question with 11 response categories ranging
from “< $5,000” to “≥ $80,000.” For regres-
sion analysis, these were condensed to four
categories: < $10,000, $10,000–19,999,
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Table 1. Characteristics of children participating
from winter 2001 through spring 2002 as reported
on baseline caregiver interview (n = 86).
Characteristic Value
Child age at start of winter 2001a 9.13 ± 1.44
Percent female 43.0
Child ethnicity (%)
African American 77.9
Latino 15.1
Other 7.0
Child location of residence (%)
Eastside 70.1
Southwest 29.9
Caregiver education (%)b
1–8 grade 8.1
9–11 grade 33.7
High school graduate/GED 27.9
Any college 30.2
Household annual income (%)
< $10,000 44.7
$10,000–20,000 32.9
$20,000–40,000 17.6
≥ $40,000 4.7
Caregiver smokes cigarettes (self-report) (%) 31.4
Any household member smokes cigarettes (%) 51.2
Child’s asthma severity (%)
Moderate–severe persistent 50.0
Mild persistent 25.6
Mild intermittent 24.4
Asthma medication use by asthma severity
Persistent (mild severe) [n = 65 (%)]b
CS 15.4
Nonsteroid controllerc 23.1
Short-acting bronchodilatord 30.8
None 30.8
Intermittent [n = 21 (%)]
CS 4.8
Nonsteroid controller 4.8
Short-acting bronchodilator 14.3
None 76.2
aMean ± SD. bPercentages may not add to 100% because
of rounding. cUse of a leukotriene modifier, long-acting
bronchodilator, cromolyn, or theophylline, but no use of a
CS. dUse of a short-acting bronchodilator but no use of
any controller medication.$20,000–39,000, and ≥ $40,000. Children
were considered to be exposed to tobacco
smoke if caregivers reported one or more ciga-
rette smokers living in the home. To adjust for
an inﬂuence of being simultaneously enrolled
in the companion home intervention study,
two indicator variables were included: whether
a child had been randomized to the interven-
tion or to the control groups, and whether the
exposure was occurring before or after the
intervention was complete. An interaction
term between intervention group and time
was also included.
In separate models, interactions of each
exposure variable with CS use or with presence
of URI were also included. This allowed the
pollution effects and the lag structure to differ
with the different types of effect modiﬁcation
being examined. We did not adjust for relative
humidity and temperature because of the high
degree of collinearity with exposure measure-
ments within several seasons. Adjusting for
season accounts for most of the variability in
temperature and humidity between seasons,
as well as other unmeasured season-specific
covariates (e.g., incidence of respiratory infec-
tions in the community).
We analyzed single-pollutant models
examining the effects of PM and O3 indepen-
dently, as well as two-pollutant models simul-
taneously including a measure of PM and of
O3. To be able to directly compare the effect
sizes across pollutants, exposures were stan-
dardized to the interquartile range for each
specific pollutant. The number of observa-
tions on which models were based varies
depending on the pattern of missing data by
pollutant, lag, and season.
Results
Demographic and Asthma
Characteristics of Cohort
Characteristics of the 86 children participating
in the last six seasons of data collection, and
thus contributing to the analyses presented
here, are shown in Table 1. Most participants
were African American, were from the eastside,
and had household annual income < $20,000.
Approximately one-half of the caregivers
reported at least one tobacco smoker in the
household. At baseline, half of the children had
symptoms consistent with moderate-to-severe
persistent asthma. Among the 65 children with
persistent asthma, fewer than one-half were
reported to be taking a controller medication
(steroid or nonsteroidal), and 30% were using
no medication at all. CS use reported on daily
diaries ranged from 13 to 26% of all partici-
pants, depending on the season. Frequency of
respiratory infection ranged from a low of 7%
of reported person-days (in spring 2001 and
spring 2002) to a high of 24% of person-days
in winter 2001. CS use and respiratory infec-
tion were uncorrelated: Of the > 1,900 person-
days of observations entering the regressions,
only 3% were contributed by children report-
ing both CS use and presence of respiratory
infection, 11% were contributed by children
reporting CS use but not respiratory infection,
and 19% by children reporting respiratory
infection but not CS use.
Description of Ambient Exposure
Measurements
Means across the six seasons of ambient
exposure measures [winter (February) 2001
through spring (May) 2002] by location are
shown in Table 2. The mean concentrations of
PM2.5 were 15.7 and 17.5 µg/m3 measured at
the eastside and southwest sites, respectively
(Table 2). In addition to seasonal variability in
PM [lowest seasonal means occurred in fall
(September) 2001: PM2.5 = 10.6 µg/m3, PM10
= 20.5 µg/m3; highest seasonal means occurred
in spring (May) 2001: PM2.5 = 23.3 µg/m3,
PM10 = 28.4 µg/m3], there was considerable
day-to-day variability in PM measurements
(lowest daily mean PM2.5 = 1.0 µg/m3, PM10 =
2.9 µg/m3; highest daily mean PM2.5 =
56.1 µg/m3, PM10 = 70.9 µg/m3). The
observed levels of pollutants were similar to
values measured at these sites during the ﬁrst
ﬁve seasons of the study, fall 1999 through fall
2000 (Keeler et al. 2002), and the Detroit area
has since been designated in nonattainment for
the annual NAAQS for PM2.5 of 15 µg/m3.
The increased levels of both PM10 and PM2.5
at the southwest site are likely due to a combi-
nation of the local proximity of heavy indus-
trial sources (including coal-ﬁred power plants,
reﬁneries, and iron/steel mills) and differences
related to trafﬁc density (e.g., diesel emissions).
As with PM, there was both seasonal vari-
ability and day-to-day variability in O3 levels
(lowest daily mean = 5.6 ppb, lowest 8 hr-peak
= 14.8 ppb; highest daily mean = 66.3 ppb,
highest 8-hr peak = 92.0 ppb). Non-negligible
levels of O3 were measured during the winter
2002 (eastside: daily mean = 22.2, 8-hr peak =
24.1; southwest: daily mean = 21.2, 8-hr peak
= 24.2). The interquartile ranges were 12.5
µg/m3, 19.1 µg/m3, 14.5 ppb, and 16.0 ppb
for PM2.5, PM10, daily O3, and 8-hr peak O3,
respectively. Correlations between PM meas-
ures and O3 measures were mostly in the
0.5–0.6 range. The intra-PM and intra-O3 cor-
relations were around 0.9 (Table 3).
Description of Lung Function
There were 12,962 error-free observations
available for analysis out of a possible 14,448
(twice-daily measures for 14 days per six sea-
sons for each of the 86 children). We restricted
our analysis to the 10,784 FEV1 observations
between 30 and 140% predicted, which repre-
sents approximately 83% of the error-free data.
Population mean lung function values for
FEV1 diurnal variability and lowest daily FEV1
are shown by use of CS medications and by
report of the presence of respiratory infection
in Table 4. These values suggest that, on aver-
age, our population experienced a mild to
moderate degree of airway obstruction. The
lack of differences between those reporting and
those not reporting respiratory infection sug-
gests that aggravation of underlying asthma
was not routinely being confused with respira-
tory infection by the respondents.
Association of Exposure and Lung
Function
Single-pollutant models. Regression models
expressing the association between ambient pol-
lutant exposure and lung function for children
on CSs are shown in Table 5. Results for chil-
dren not on CSs are not presented, because no
statistically signiﬁcant relationships were identi-
ﬁed at the p = 0.05 level. Associations for chil-
dren reporting presence of URI symptoms are
shown in Table 5. Only one statistically signiﬁ-
cant relationship was observed for children who
did not report respiratory infection symptoms
(described in “Additional analyses,” below).
All associations with p-values < 0.2 were in
the expected direction (increased pollutant
associated with increased FEV1 diurnal vari-
ability and decreased lowest daily value), indi-
cating consistency across the models examined.
For children on maintenance CSs, PM10 and
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Table 2. Ambient pollutant and meteorologic measurements (mean ± SD) in two Detroit communities aver-
aged across six seasons (winter 2001 through spring 2002).
Measurement Eastside Southwest Interquartile range
PM2.5 daily mean (µg/m3) 15.7 ± 10.6 17.5 ± 12.2 12.5
PM10 daily mean (µg/m3) 23.0 ± 13.5 28.2 ± 16.1 19.1
O3 daily meana (ppb) 27.6 ± 12.5 26.5 ± 9.8 14.5
O3 peak 8-hr meana (ppb) 40.4 ± 18.2 41.4 ± 18.6 16.0
Temperature (°C) 11.5 ± 9.8 11.7 ± 9.8
Relative humidity (%) 72.2 ± 14.1 73.1 ± 14.7
aO3 was not measured during winter 2001.
Table 3. Pearson correlation matrix of pollutant
measures made in two locations (eastside and
southwest) during six seasons (winter 2001 through
spring 2002).
Daily mean O3
Pollutant PM10 O3 8-hr peak
PM2.5 daily mean 0.93 0.57 0.53
PM10 daily mean 0.59 0.57
O3 daily mean 0.878-hr peak O3 were both associated with poorer
lung function 2 days after exposure. For chil-
dren reporting symptoms of respiratory infec-
tion, both PM2.5 and PM10 were associated
with poorer lung function 3–5 days after expo-
sure. O3, particularly the 8-hr peak concentra-
tion, was associated with poorer lung function,
predominantly at lag 1 and lag 2. In general,
the estimated effect sizes were modest and were
in similar ranges for PM and for O3.
Two-pollutant models. In models includ-
ing either of the PM measurements simultane-
ously with daily mean O3, all associations with
p-values < 0.1 were in the expected direction
(Tables 6 and 7). The pattern of these associa-
tions differed from that in the single-exposure
models, most likely owing to differences in
missing data patterns across these analyses. The
two-pollutant models suggest that PM and O3
independently affect lung function, even after
adjustment was made for the effect of the other
pollutant. Among children taking CSs (Table
6), the combination of PM2.5 and daily O3 was
more likely to have a signiﬁcant effect in the
longer lags, whereas the effects of PM10 and
daily O3 were seen in both shorter and longer
lags. A similar pattern was also seen among
children reporting respiratory infection on the
day of lung function assessment (Table 7).
Some of the largest and most signiﬁcant effect
estimates were seen for the models including
PM10 and O3 among those children with respi-
ratory infections.
Additional analyses. Regressions including
either of the PM measures simultaneously
with 8-hr peak O3 also showed associations
with lung function in the expected direction,
although these were statistically significant
slightly less often than the presented PM/daily
O3 models.
We examined identical models using PF
as an alternative health outcome. Data clean-
ing for PF was the same as for FEV1, except
that, based on the distribution of the data, a
slightly narrower range of values were consid-
ered valid (values between 30 and 120% pre-
dicted). As with FEV1 models, PF models
showed multiple statistically signiﬁcant associ-
ations between pollutants and respiratory out-
comes, with all but one of these associations
seen among children who either used CSs or
who reported URIs. In general, the pattern of
signiﬁcant associations was similar in the PF
and the FEV1 models. There were several
instances where an exposure would be signiﬁ-
cantly associated with worsening lung func-
tion in the FEV1 model and in the PF model
would have a point estimate in the expected
direction of worse lung function, but where
the p-value was > 0.05, implying that FEV1
was a more sensitive indicator than PF for
pollution effects on lung function.
The vast majority of analyses for children
not on CSs or not reporting a URI did not
show signiﬁcant associations (data not shown).
Of the 144 models examined (associations
between PM2.5, PM10, daily O3, and 8-hr peak
O3 exposures singly or jointly with FEV1 or PF
diurnal variability or lowest daily value), only
four models showed significant associations
between pollutants and lung function in the
groups not on CSs or not reporting URIs.
These exceptions are described here. Among
children without URIs, a) the single-pollutant
model examining the association between
PM10 and diurnal variability in PF at lag 1
showed an odds ratio (OR) of 1.72 [95% con-
ﬁdence interval (CI), 0.38 to 3.06; p = 0.012],
whereas among children with URIs, OR =
1.83 (95% CI, –4.26 to 7.91; p = 0.56); and
b) the two-pollutant model of PM10 and daily
O3 exposure on diurnal variation of FEV1 at
lag 1 showed an OR for O3 exposure of 3.27
(95% CI, 0.30 to 6.23; p = 0.03; OR for PM10
was not signiﬁcant), contrasted with children
with URIs (OR for O3 exposure = 9.53; 95%
CI, 5.82 to 13.47; p < 0.001; OR for PM10
was not signiﬁcant). For children not on CSs,
a) the two-pollutant model evaluating the joint
effects of PM2.5 and daily O3 exposure on
diurnal variation of FEV1 at lag 3–5 days
showed an OR for PM2.5 exposure of 2.21
(95% CI, 0.26 to 4.16; p = 0.03; OR for O3
exposure was not signiﬁcant), contrasted with
children on CSs (OR for PM2.5 exposure =
2.70; 95% CI, 1.0 to 4.40; p = 0.002; OR for
O3 exposure was not significant); and b) the
Lewis et al.
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Table 4. Distribution of valid FEV1 diurnal variabilitya and lowest daily FEV1
a values (mean ± SD) over the
six seasonal assessment periods by at-risk status determined by seasonal diary (winter 2001 through
spring 2002).
Subgroup of children Person-days (n) Variability FEV1 Lowest daily FEV1
On CSsa 393 15.8 ± 14.2 78.1 ± 17.5
Not on CSs 1,545 15.0 ± 11.6 71.7 ± 18.9
Reporting URIa 231 14.9 ± 12.3 74.0 ± 19.0
Not reporting URI 1,481 15.7 ± 12.3 71.5 ± 19.4
aSee “Materials and Methods” for deﬁnitions.
Table 5. Associations of ambient pollutant concentrations with lung function of children with asthma: single-pollutant models.a
Daily mean
PM2.5 PM10 O3 O3 daily 8-hr peak
Lung functionb Coefﬁcientc 95% CI p-Value Coefﬁcient 95% CI p-Value Coefﬁcient 95% CI p-Value Coefﬁcient 95% CI p-Value
Among children reporting use of maintenance CSsd
Diurnal variability FEV1
Lag 1e 1.61 –0.50 to 3.72 0.14 1.53 –0.85 to 3.90 0.21 –0.41 –3.02 to 2.19 0.76 1.75 –0.20 to 3.70 0.08
Lag 2e 2.96 –1.74 to 7.66 0.22 5.32 0.32 to 10.33 0.04 –0.73 –3.21 to 1.75 0.56 3.19 0.29 to 6.08 0.03
Lag 3–5e 1.37 –1.49 to 4.22 0.35 1.46 –2.21 to 5.13 0.43 –1.86 –4.86 to 1.14 0.22 –0.03 –0.28 to 0.22 0.82
Lowest daily value FEV1
Lag 1e –2.23 –6.99 to 2.53 0.36 –0.28 –2.34 to 1.77 0.79 –0.28 –4.94 to 4.39 0.91 –1.0 –5.68 to 3.68 0.68
Lag 2e –0.21 –4.09 to 3.68 0.92 –2.21 –3.97 to –0.46 0.01 0.21 –3.06 to 3.48 0.90 –3.95 –6.78 to –1.12 0.006
Lag 3–5e –0.76 –5.00 to 3.49 0.73 –2.58 –7.65 to 2.49 0.32 –1.05 –7.68 to 5.58 0.76 0.07 –0.28 to 0.41 0.70
Among children reporting presence of URI on day of lung function assessment
Diurnal variability FEV1
Lag 1e 2.00 –2.64 to 6.64 0.40 3.51 –4.52 to 11.55 0.39 4.08 –1.78 to 9.94 0.17 5.79 1.74 to 9.85 0.005
Lag 2e 0.35 –5.90 to 6.60 0.91 1.12 –4.62 to 6.86 0.70 7.62 –0.49 to 15.73 0.07 4.74 0.46 to 9.02 0.03
Lag 3–5e 2.51 0.06 to 4.95 0.05 3.90 0.34 to 7.47 0.03 1.47 –7.73 to 10.67 0.75 0.27 0.01 to 0.53 0.04
Lowest daily value FEV1
Lag 1e –1.21 –5.62 to 3.21 0.59 –2.72 –9.47 to 4.03 0.43 –2.65 –6.16 to 0.87 0.14 –3.00 –5.16 to –0.84 0.007
Lag 2e –0.10 –4.36 to 4.16 0.96 –0.24 –5.10 to 4.63 0.92 –4.36 –8.26 to –0.47 0.03 –2.64 –5.45 to 0.18 0.07
Lag 3–5e –2.88 –5.46 to –0.30 0.03 –4.48 –8.36 to –0.60 0.02 –1.01 –3.98 to 1.96 0.50 –0.03 –0.18 to 0.12 0.70
aEach coefﬁcient is an estimate of percent change in lung function shown and is derived from a separate linear regression model using GEE. Covariates in each model: sex, home location,
annual family income, presence of one or more smokers in household, race, season, randomization assignment for the intervention, and interaction between time and this randomization
assignment. bAssessment of a child’s lung function based on error-free expiratory maneuvers. cThe regression coefﬁcient is the estimated change in lung function associated with an
increase of one interquartile range in the ambient pollutant concentration. dRegressions pertain to those children reporting use of inhaled and/or oral CSs at least 50% of days in a given
season on diary. eNumber of days between measurement of ambient pollutant concentration and lung function; lag 3–5 is based on the mean of pollutant concentrations on those days.two-pollutant model of PM10 and daily O3 on
diurnal variation of FEV1 at lag 3–5 days
showed an OR for PM10 exposure of 2.92
(95% CI, 0.74 to 5.11; p = 0.009; OR for O3
exposure not signiﬁcant), contrasted with chil-
dren using CSs (OR for PM10 exposure 3.30;
95% CI, 0.58 to 6.02; p = 0.02; OR for O3
exposure not signiﬁcant).
Discussion
PM2.5 and 8-hr O3 concentrations in Detroit
measured in this study are close to or exceed
the updated NAAQS standards, whereas lev-
els of PM10 are well within current standards.
Our findings in single- and two-pollutant
regression models strongly suggest that these
levels of air pollutants were associated with
adverse effects on pulmonary function among
at-risk children with asthma. Among the sub-
group of asthmatic children using mainte-
nance CSs, single-pollutant models suggest
lag 2 effects for PM10 and 8-hr peak O3. The
two-pollutant models revealed effects more
broadly across various lags for children on
steroids. For children reporting respiratory
infection, the single-pollutant models showed
PM effects in later lags and a striking O3
effect, particularly when examining the 8-hr
peak concentration. In several of these two-
pollutant models, PM and O3 measures
simultaneously showed statistically signiﬁcant
associations with poorer lung function,
strongly suggesting the presence of indepen-
dent effects. Moreover, the fact that the same
single- and two-pollutant models for children
not on CSs and, separately, children without
a current URI showed essentially no signifi-
cant associations between any pollutant meas-
ures and any lung function measures greatly
decreases the likelihood that some kind of
unrecognized systematic bias is responsible
for the positive ﬁndings among those on CSs
or with URIs. On the whole, the observed
effects, although mostly modest in absolute
terms, appear quite statistically robust.
Strengths of our study include multiple
assessments of air pollution and lung function
across seasons; the use of FEV1 as an outcome
measure; an ability to examine two suscepti-
ble subgroups—children on maintenance CSs
and children reporting respiratory infections;
an ability to examine simultaneous effects of
O3 and suspended particles; and a CBPR
approach that contributed to high retention
of participants across seasons.
Several limitations of this study need to be
considered. The data presented here are based
on 86 children from an original group of
510 eligible children with persistent asthma
who were successfully contacted, raising the
potential for selection biases affecting expo-
sure–health outcome associations. It appears
unlikely that such biases are substantively oper-
ative given that a) demographic and disease
status of the 86 children for whom data are
analyzed here were very similar to those of the
other 212 children who began the study; b) the
basis on which the 86 were chosen (i.e., having
at least one other participating child present in
the same school) is very unlikely to be associ-
ated with the magnitude of the child’s health
response to air pollutants; and c) in that, in
this longitudinal design, each child essentially
serves as his or her own control, different dis-
tributions of unmeasured covariates among the
86 compared with the other children are sub-
stantially less likely to affect exposure–health
outcome associations.
Repeated measurements of lung function
in the community setting are notoriously difﬁ-
cult to obtain accurately. This was corrobo-
rated by our own experience with the first
Air pollution effects in children with asthma
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Table 6. Associations of ambient pollutant concentrations with lung function among children with asthma
reporting use of maintenance CSs: two-pollutant models.a,b
PM2.5 daily mean O3 daily mean
Lung functionc Coefﬁcientd 95% CI p-Value Coefﬁcient 95% CI p-Value
Effect of concurrent exposure to both PM2.5 and O3
Diurnal variability FEV1
Lag 1e 0.99 –5.64 to 7.62 0.77 1.27 –3.58 to 6.11 0.61
Lag 2e 4.62 –4.31 to 13.54 0.31 3.51 –3.79 to 10.81 0.35
Lag 3–5e 2.70 1.0 to 4.40 0.002 3.76 0.27 to 7.26 0.04
Lowest daily value FEV1
Lag 1e 3.36 –3.92 to 10.63 0.37 –2.53 –9.78 to 4.71 0.49
Lag 2e 0.88 –8.69 to 10.46 0.86 –0.13 –8.09 to 7.83 0.98
Lag 3–5e –2.78 –4.87 to –0.70 0.009 –2.81 –9.02 to 3.41 0.38
Effect of concurrent exposure to PM10 and O3
Diurnal variability FEV1
Lag 1e 2.94 –1.07 to 6.96 0.15 5.32 1.82 to 8.82 0.003
Lag 2e 13.73 8.23 to 19.23 < 0.001 5.55 1.93 to 9.17 0.003
Lag 3–5e 3.30 0.58 to 6.02 0.02 –1.63 –6.97 to 3.72 0.55
Lowest daily value FEV1
Lag 1e –6.25 –11.15 to –1.36 0.01 –2.33 –4.85 to 0.02 0.07
Lag 2e –5.97 –11.06 to –0.87 0.02 –9.92 –13.28 to –6.56 < 0.001
Lag 3–5e 1.98 –0.38 to 4.33 0.10 –4.56 –7.92 to –1.20 0.008
aEach coefﬁcient is an estimate of percent change in lung function shown and is derived from a separate linear regres-
sion model using GEE. Covariates in each model: sex, home location, annual family income, presence of one or more
smokers in household, race, season, randomization assignment for the intervention, and interaction between time and
this randomization assignment. bRegressions pertain to those children reporting use of inhaled and/or oral CSs at least
50% of days in a given season on diary. cAssessment of a child’s lung function based on error-free expiratory maneuvers.
dThe regression coefficient is the estimated change in lung function associated with an increase of one interquartile
range in the ambient pollutant concentration. eNumber of days between measurement of ambient pollutant concentration
and lung function. Lag 3–5 is based on the mean of pollutant concentrations on those days.
Table 7. Associations of ambient pollutant concentrations with lung function among children with asthma
reporting symptoms of URI: two-pollutant models.a,b
PM2.5 daily mean O3 daily mean
Lung functionc Coefﬁcientd 95% CI p-Value Coefﬁcient 95% CI p-Value
Effect of concurrent exposure to both PM2.5 and O3
Diurnal variability FEV1
Lag 1e 3.99 –2.76 to 10.74 0.25 4.69 –0.72 to 10.09 0.09
Lag 2e 4.10 –1.41 to 9.60 0.15 6.51 –1.96 to 14.98 0.13
Lag 3–5e 3.81 –1.83 to 9.45 0.19 3.52 –1.27 to 8.30 0.15
Lowest daily value FEV1
Lag 1e –0.74 –4.14 to 2.65 0.67 –2.82 –6.34 to 0.70 0.12
Lag 2e –1.67 –5.09 to 1.75 0.34 –3.99 –7.54 to –0.44 0.03
Lag 3–5e –2.78 –4.79 to –0.77 0.007 –2.16 –14.59 to 10.28 0.73
Effect of concurrent exposure to PM10 and O3
Diurnal variability FEV1
Lag 1e 3.21 –1.28 to 7.71 0.16 9.53 5.58 to 13.47 < 0.001
Lag 2e 5.40 –0.82 to 11.62 0.09 7.66 –0.50 to 15.83 0.07
Lag 3–5e 6.27 0.07 to 12.47 0.05 2.53 –8.40 to 13.45 0.65
Lowest daily value FEV1
Lag 1e –13.11 –21.59 to –4.62 0.003 –4.41 –7.81 to –1.00 0.01
Lag 2e –3.32 –6.83 to 0.18 0.06 –5.22 –8.29 to –2.16 0.001
Lag 3–5e –3.17 –5.82 to –0.51 0.02 1.97 –2.56 to 6.51 0.39
aEach coefﬁcient is an estimate of percent change in lung function shown, and is derived from a separate linear regres-
sion model using GEE. Covariates in each model: sex , home location, annual family income, presence of one or more
smokers in household, race, season, randomization assignment for the intervention, and interaction between time and
this randomization assignment. bRegressions pertain to those children reporting URI on the day of lung function assess-
ment. cAssessment of a child’s lung function based on error-free expiratory maneuvers. dThe regression coefﬁcient is the
estimated change in lung function associated with an increase of one interquartile range in the ambient pollutant con-
centration. eNumber of days between measurement of ambient pollutant concentration and lung function. Lag 3–5 is
based on the mean of pollutant concentrations on those days.Airwatch model and protocol, and prompted
our switch to the updated Airwatch 2 model
and change in protocol to allow supervision
and coaching of a large portion of the lung
function data collection. These changes sub-
stantially improved the reproducibility of PF
and FEV1 measurements based on visual
inspection of the data and supported by a
reduction in the within-child intra-half-day
coefﬁcient of variation (0.202 vs. 0.102 for PF,
and 0.238 vs. 0.114 for FEV1). During the
final data collection period (May 2002), we
performed an exercise to validate the Airwatch
data. We compared morning FEV1 values
obtained by an experienced respiratory thera-
pist at the child’s school using a standard
spirometer (Renaissance II; Puritan Bennett,
Pleasanton, CA) to those error-free FEV1 val-
ues obtained the same morning with Airwatch
while the child was being coached in the usual
manner by study staff for a convenience sample
of 37 children. After removal of two outliers
with clearly invalid technique, the mean differ-
ence (spirometry value – Airwatch value) was
–0.14 L. A t-test revealed that this value is not
statistically different than zero. Lung function
values obtained by spirometry were in general
quite reproducible (mean difference between
two best blows, 0.19 L). This reproducibility
measure was unassociated with pollution levels
of either PM or O3, so there is no indication
that ambient pollution levels differentially
affected the quality of expiratory maneuvers.
To help guard against the potential for
spurious associations due to inaccuracies in
lung function measures, we opted to exclude
very high (> 140% predicted) or very low
(< 30% predicted) lung function values, which
were expected to be most likely a result of sub-
optimal exhalation technique. If this data-
cleaning step inadvertently excluded some
valid data, the effect would be to blunt the
true variability in lung function, most likely
biasing ﬁndings toward the null hypothesis.
The data set used for regression models was
limited by the decision to use only FEV1 meas-
ures from the revised protocol in place during
the last six seasons and from some limits on the
exposure data collected (i.e., PM exposures
were determined only on days on which lung
function was measured, and O3 measurements
were made only during one winter). These
restrictions should not introduce any system-
atic bias, and most of those models with
modest effect estimates size of 2–3% reached
statistical significance at the p = 0.05 level,
indicating retention of reasonable power.
Another potential limitation was our
reliance on caregiver report for information
about asthma severity, medication use, and
presence of URI symptoms. There was no
independent method to verify these reports.
We also did not attempt to learn what medi-
cations the child’s physician had actually
prescribed; rather, we focused on what the
child was actually taking through daily diary
reports. Although there may be some misclas-
siﬁcation of steroid use, our ability to detect a
difference in the effect of pollutants among
those we classiﬁed as steroid users compared
with nonusers reassures us that our methods
and deﬁnitions were able to separate the chil-
dren into clinically meaningful groups. It is
also possible that unmeasured characteristics
of the children or their home environment
may have influenced their responsiveness to
pollutants that were not included in our mod-
els. However, beyond the changes attributable
to the household intervention (which were
included in our models), these characteristics
were unlikely to vary much within the same
individual and therefore were unlikely to con-
found the observed relationships.
The pattern of association within each
group was not always consistent across lags or
between the single- and two-pollutant models,
a common finding in the literature (Delfino
et al. 2002; Gent et al. 2003; van der Zee et al.
1999). Factors that may contribute to this phe-
nomenon here include the following: a) The
set of observations on which regressions were
based varied somewhat among models because
each model used all available data for the con-
tributing variables; b) some within-season cor-
relations between PM and O3 (particularly in
the summer months) were higher than the
general correlations, which may have influ-
enced standard error calculations; and c) our
data-cleaning steps may have been too conserv-
ative, potentially obscuring true relationships.
Because of practical field measurement
conditions, we were limited to examination of
PF and FEV1. Although FEV1 is a more sensi-
tive indicator of lower airway function than is
PF, measures of small airway function, such as
FEF25–75, could have been even more sensitive
and might have been able to detect more con-
sistent relationships. We examined two differ-
ent parameters of the lung function measures
(diurnal variability and lowest daily value) to
capture slightly different potential inﬂuences
on airways. Diurnal variability in PF has been
shown to correlate with symptoms (Gern et al.
1994) and responsiveness to methacholine
(Gibson et al. 1995; Valletta et al. 1995), and
to be more sensitive to changes in the environ-
ment than the mean absolute value of PF
(Valletta et al. 1995). We extrapolated that a
similar phenomenon might be likely with
FEV1. Diurnal variability and lowest daily
value were expected to track together, but not
necessarily to be concordant (Brand et al.
1997; Valletta et al. 1995), which was what
we observed. We feel that the weight of the
evidence—specifically, the presence of many
statistically signiﬁcant associations of pollution
and lung function among children taking
CSs regularly or children reporting respiratory
infection versus none or few signiﬁcant associ-
ations among children lacking these character-
istics—combined with the generally consistent
pattern of effect estimates in the expected
direction across models, supports the existence
of a true underlying relationship.
The relationship of routine asthma medica-
tion use to observed health effects of air pollu-
tion is complex, because it sometimes appears
to be a marker for disease severity and at other
times appears to protect against the adverse
effects of pollution. An assessment of the effect
of sulfur dioxide on mild asthmatic patients in
the Czech Republic in 1991–1992 showed an
inverse association between air pollutant levels
and PF for children on medication (either theo-
phylline or beta-agonists; no children were on
CSs) but not for children not on medication
(Peters et al. 1997). Another study (Gent et al.
2003) found consistent effects of O3 and PM
on respiratory symptoms among those children
using maintenance medication for asthma but
not among medication nonusers. These authors
concluded that asthma medication serves as a
proxy for disease severity in their analyses. In
studies that have compared groups of asthmatic
children with similar frequencies of symptoms
at baseline, positive associations between expo-
sure to O3, PM10, and nitrogen dioxide and
symptoms were present only among those not
taking anti-inﬂammatory medications (CSs or
cromolyn) (Delﬁno et al. 1998, 2002). A mixed
picture was seen by Mortimer et al. (2000):
Among children who were full-term or normal
birth weight, children on cromolyn were more
symptomatic in response to O3 exposure than
were those who were on no medication or were
on beta-agonists, methylxanthines, or steroids;
but among preterm or low-birth-weight chil-
dren, those who did not use any medications
were more symptomatic than those on any type
of medication. In our cohort, CS use appears to
act as a proxy for disease severity. It appears
possible that there is subclinical airway inﬂam-
mation or preexisting airway remodeling that is
“unmasked” by exposure to higher air pollutant
levels, resulting in greater pollution-related
effects on lung function among children
on CSs.
Our investigation is consistent with the few
other studies that have examined the relation-
ship between pollution exposure and asthma
exacerbation associated with viral illness. Tarlo
et al. (2001) reported that asthma exacerba-
tions with diary-reported colds were associated
with higher levels of sulfur dioxide and nitro-
gen oxides compared with exacerbations with-
out colds. Chauhan et al. (2003) found that
participants exposed to high levels of NO2 in
the week before the onset of polymerase-chain-
reaction confirmed virally induced exacerba-
tion had worse symptom scores and lower PF
than did participants exposed to low levels of
NO2 before their virally induced exacerbations.
Lewis et al.
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Potential mechanisms by which pollutants may
increase susceptibility to viral infection include
disruption of mucociliary clearance (Ehrlich
1980; Schlesinger and Driscoll 1987), impair-
ment of cellular immunity (Zwick et al. 1991),
or release of inﬂammatory mediators (Rusznak
et al. 1996).
In summary, in our population of predom-
inantly African-American and Latino children
living in the economically stressed city of
Detroit, children with asthma who were CS
dependent or who had URIs were adversely
affected by current levels of ambient air pollu-
tion. Our results emphasize the continued
need for enforcement of existing standards as
well as the importance of considering suscepti-
ble subgroups within the population when for-
mulating new standards. CBPR partnerships
can play a critical role in this policy process.
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CORRECTION
The “Demographic and Asthma Character-
istics of Cohort” section of “Results” in the
manuscript originally published online was
incorrect in describing less than two-thirds
and 15% of the cohort; it has been corrected
here to fewer than one-half and 30%.